• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Stemgent

edit

Stemgent works alongside some of the world’s leading stem cell scientists in developing innovative technology and application solutions that provide researchers the tools to investigate and understand cellular reprogramming. Our mission is to help simplify and support stem cell research by producing products and services being designed by leading stem cell researchers. Specialties Cellular Reprogramming, iPS Cells, Media, Human iPSC Training & Services, mRNA Reprogramming, Stem Cell Research, Custom iPS cell lines, Pluriton, WIT, StainAlive, NutriStem

Recent Milestones

edit

• 
  Stemgent received $11.3M in Venture Round funding. (8/13/12)
  Posted 8/13/12 at 6:16pm via masshightech.com
• 
  Stemgent — Stemgent to buy Asterand’s human tissue biz for $9M (6/11/12)
  Posted 6/11/12 at 7:33pm via masshightech.com
• 
  Stemgent received $6.3M in Venture Round funding. (2/1/12)
  Posted 2/1/12 at 6:55pm via masshightech.com
• 
  Stemgent received $580k in Debt funding. (10/31/11)
  Posted 10/31/11 at 6:19pm via masshightech.com
• 
  Stemgent received $5.6M in Series B funding. (7/19/10)
  Posted 7/19/10 at 3:30pm via onbiovc.com
• 
  Stemgent received $2.7M in Debt funding. (11/25/09)
  Posted 11/26/09 at 7:18am via masshightech.com
• 
  Stemgent received $14M in Series B funding. (3/1/09)
  Posted 4/14/09 at 6:26am via xconomy.com
• 
  Stemgent added Daniel X Moore as Software Engineer. (3/1/08)
  Posted 9/15/11 at 9:41am

Videos

Screenshots

edit

Above: Home Page
Uploaded: 11/26/09

Sources

1. Stemgent Nails Down $14M to Make Supplies, Tools for Stem Cell Researchers (xconomy.com) [edit]
2. Stemgent issues notes to raise $2.7M (masshightech.com) [edit]
3. Stemgent, Inc.: Series B $5.6M (onbiovc.com) [edit]
4. Stemgent grabs $580K in debt funding (masshightech.com) [edit]
5. Stemgent adds $6.3M to coffers to grow portfolio (masshightech.com) [edit]
6. Stemgent rakes in $11M, largest round to date (masshightech.com) [edit]
Stemgent to buy Asterand’s human tissue biz for $9M (masshightech.com) [edit]